UG Q2 2025 Earnings Profitability Maintained Amid Modest Stock Reaction Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues Ovintiv Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline JLL Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty IBEX Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher KORE Q1 2026 Earnings Massive EPS Miss Revenue Data Unavailable